Clinical Consultation Guide: Nerve-sparing Techniques for Retroperitoneal Lymph Node Dissection in Testicular Cancer

Khor V 1 , Chen K 2 , Somasundram LM 3 , Lawrentschuk N 4

Affiliations 

  • 1 Department of Urology, Hospital Sultan Abdul Aziz Shah, Universiti Putra Malaysia, Selangor, Malaysia
  • 2 Department of Urology, Singapore General Hospital, Singapore; Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore. Electronic address: kenneth.chen@singhealth.com.sg
  • 3 Monash University, Clayton Campus, Melbourne, Australia
  • 4 Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; EJ Whitten Prostate Cancer Research Centre, Melbourne, Australia; Department of Surgery (Urology), Royal Melbourne Hospital, Melbourne Victoria, Australia
Eur Urol Focus, 2024 May;10(3):364-366.
PMID: 38839507 DOI: 10.1016/j.euf.2024.05.008

Abstract

Reptroperitoneal lymph node dissection (RPLND) is associated with a risk of morbidity and ejaculatory dysfunction. Nerve-sparing RPLND shows promise in preserving ejaculation alongside oncological efficacy. Laparoscopic and robot-assisted modalities are feasible with good outcomes, highlighting the need for ongoing scientific research and refinement of surgical skills.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications